Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
This medicine has the best evidence for effectiveness and safety. |
| Bahamas. Drug Formulary | 10. ANTINEOPLASTIC AND RELATED AGENTS | No observations |
| List | Section | Observation |
|---|---|---|
| Bahamas. Drug Formulary | 10. ANTINEOPLASTIC AND RELATED AGENTS | No observations |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Antineoplastic Agents | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 41. Antineoplásicos y agentes inmunomoduladores | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 17. ONCOLOGIA | No observations |
| WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
This medicine has the best evidence for effectiveness and safety. |
| Bahamas. Drug Formulary | 10. ANTINEOPLASTIC AND RELATED AGENTS | No observations |